Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Neuro-Degenerative Diseases
|
October 16, 2007
Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease
M C Irizarry, Y Yao, B T Hyman, et al.
Acta Neuropathologica
|
April 29, 2000
alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining
E Gómez-Tortosa, K Newell, M C Irizarry, et al.
Neuroreport
|
May 8, 2001
Uptake of fibrillar beta-amyloid by microglia isolated from MSR-A (type I and type II) knockout mice
H Chung, M I Brazil, M C Irizarry, et al.
The American Journal of Pathology
|
September 11, 2001
Elevation of cystatin C in susceptible neurons in Alzheimer's disease
A Deng, M C Irizarry, R M Nitsch, et al.
Neurology
|
October 16, 1999
Clinical and quantitative pathologic correlates of dementia with Lewy bodies
E Gómez-Tortosa, K Newell, M C Irizarry, et al.
Neurology
|
January 21, 2009
Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial
A Viswanathan, S Raj, S M Greenberg, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 15, 1997
Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse
M C Irizarry, F Soriano, M McNamara, et al.
Annals of the New York Academy of Sciences
|
February 24, 2001
Modulation of A beta deposition in APP transgenic mice by an apolipoprotein E null background
M C Irizarry, G W Rebeck, B Cheung, et al.
Acta Neuropathologica
|
October 25, 2000
Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice
M C Irizarry, B S Cheung, G W Rebeck, et al.
Biophysical Journal
|
February 27, 1999
Dynamics of plaque formation in Alzheimer's disease
B Urbanc, L Cruz, S V Buldyrev, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Neuro-Degenerative Diseases
|
October 16, 2007
Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease
M C Irizarry, Y Yao, B T Hyman, et al.
Acta Neuropathologica
|
April 29, 2000
alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining
E Gómez-Tortosa, K Newell, M C Irizarry, et al.
Neuroreport
|
May 8, 2001
Uptake of fibrillar beta-amyloid by microglia isolated from MSR-A (type I and type II) knockout mice
H Chung, M I Brazil, M C Irizarry, et al.
The American Journal of Pathology
|
September 11, 2001
Elevation of cystatin C in susceptible neurons in Alzheimer's disease
A Deng, M C Irizarry, R M Nitsch, et al.
Neurology
|
October 16, 1999
Clinical and quantitative pathologic correlates of dementia with Lewy bodies
E Gómez-Tortosa, K Newell, M C Irizarry, et al.
Neurology
|
January 21, 2009
Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial
A Viswanathan, S Raj, S M Greenberg, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 15, 1997
Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse
M C Irizarry, F Soriano, M McNamara, et al.
Annals of the New York Academy of Sciences
|
February 24, 2001
Modulation of A beta deposition in APP transgenic mice by an apolipoprotein E null background
M C Irizarry, G W Rebeck, B Cheung, et al.
Acta Neuropathologica
|
October 25, 2000
Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice
M C Irizarry, B S Cheung, G W Rebeck, et al.
Biophysical Journal
|
February 27, 1999
Dynamics of plaque formation in Alzheimer's disease
B Urbanc, L Cruz, S V Buldyrev, et al.
Page
of 4